Revision history of "New Zymomona mobile antimicrobial peptides for use in the treatment of skin and soft tissue infections" (Q3056453)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

23 March 2024

12 June 2023

3 August 2022

  • curprev 20:0720:07, 3 August 2022DG Regio talk contribs 122,679 bytes +82,561 Changed label, description and/or aliases in et, lt, hr, el, sk, fi, pl, hu, cs, ga, sl, bg, mt, pt, da, ro, sv, nl, fr, de, it, lv, es, and other parts: Adding translations: et, lt, hr, el, sk, fi, pl, hu, cs, ga, sl, bg, mt, pt, da, ro, sv,

12 January 2022

11 January 2022

28 November 2021

  • curprev 18:0118:01, 28 November 2021DG Regio talk contribs 30,987 bytes +4,418 Created claim: summary (P836): Nieuwe antimicrobiële peptiden van Zymomonas mobileis voor de behandeling van huid- en wekeweefselinfecties.Skin- en zachte weefselinfecties (huid- en zachte weefselinfecties) behoren tot de meest voorkomende bacteriële infecties bij mensen. AML-veroorzakende bacteriën vertonen toenemende resistentie tegen veelgebruikte antibiotica en is momenteel een van de toonaangevende categorieën van nosocomial pathogenen. Aangezien antimicrobiële peptiden...
  • curprev 18:0118:01, 28 November 2021DG Regio talk contribs 26,569 bytes +183 Changed label, description and/or aliases in nl: translated_label
  • curprev 09:2509:25, 28 November 2021DG Regio talk contribs 26,386 bytes +4,305 Created claim: summary (P836): Neue antimikrobielle Peptide von Zymomonas mobileis zur Behandlung von Haut- und Weichgewebeinfektionen. Haut- und Weichgewebeinfektionen (Haut- und Weichgewebeinfektionen) gehören zu den häufigsten bakteriellen Infektionen beim Menschen. AML-verursachte Bakterien zeigen eine zunehmende Resistenz gegen gängige Antibiotika und ist derzeit eine der führenden Kategorien von nosokomialen Krankheitserregern. Da antimikrobielle Peptide (AMPs) in versc...
  • curprev 09:2509:25, 28 November 2021DG Regio talk contribs 22,081 bytes +163 Changed label, description and/or aliases in de: translated_label

25 November 2021

  • curprev 19:3419:34, 25 November 2021DG Regio talk contribs 21,918 bytes +4,670 Created claim: summary (P836): Nouveaux peptides antimicrobiens de Zymomonas mobileis pour le traitement des infections de la peau et des tissus mous.Les infections de la peau et des tissus mous (infections de la peau et des tissus mous) sont parmi les infections bactériennes les plus courantes chez l’homme. Les bactéries productrices de LAM présentent une résistance croissante aux antibiotiques couramment utilisés et sont actuellement l’une des principales catégories d’agent...
  • curprev 19:3419:34, 25 November 2021DG Regio talk contribs 17,248 bytes +178 Changed label, description and/or aliases in fr: translated_label

27 September 2021

10 September 2021

15 July 2021

  • curprev 12:3512:35, 15 July 2021DG Regio talk contribs 16,650 bytes +162 Changed label, description and/or aliases in en: translated_label
  • curprev 12:3512:35, 15 July 2021DG Regio talk contribs 16,488 bytes +4,096 Created claim: summary (P836): New antimicrobial peptides obtained from Zymomonas mobile for use in the treatment of skin and soft tissue infections.Skin and soft tissue infections (SPAs) are among the most common bacterial infections in humans. HAMI-causing bacteria show increasing resistance to commonly used antibiotics and are now one of the leading categories of nosocomial pathogens. Because antimicrobial peptides (AMP) act on a variety of bacterial and fungal strains tha...

14 July 2021

13 July 2021